Return to homepagePandemic Pact

Pneumonia & Pandemic Preparedness

Grant number: INV-046068

Grant search

Key facts

  • Disease

    Bacterial infection caused by Klebsiella pneumonia

  • Start & end year

    2022
    2023

  • Known Financial Commitments (USD)

    $27,569

  • Funder

    Gates Foundation

  • Research Location

    United States of America

  • Lead Research Institution

    University of Maryland, Baltimore

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

to review literature for primary research articles pertaining to Klebsiella pneumoniae O-antigen as a vaccine target and the role of O-antigen-specific antibody responses in protection against systemic infections with Klebsiella pneumoniae

1 Publication linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

Klebsiella pneumoniae Lipopolysaccharide as a Vaccine Target and the Role of Antibodies in Protection from Disease.